Intuitive Surgical (ISRG) : Baillie Gifford Co reduced its stake in Intuitive Surgical by 2.36% during the most recent quarter end. The investment management company now holds a total of 1,596,759 shares of Intuitive Surgical which is valued at $1,110,609,755 after selling 38,647 shares in Intuitive Surgical , the firm said in a disclosure report filed with the SEC on Aug 9, 2016.Intuitive Surgical makes up approximately 1.83% of Baillie Gifford Co’s portfolio.
Other Hedge Funds, Including , Ubs Asset Management Americas Inc reduced its stake in ISRG by selling 162,771 shares or 49.71% in the most recent quarter. The Hedge Fund company now holds 164,638 shares of ISRG which is valued at $114,512,315. Intuitive Surgical makes up approx 0.13% of Ubs Asset Management Americas Inc’s portfolio.Ipswich Investment Management boosted its stake in ISRG in the latest quarter, The investment management firm added 25 additional shares and now holds a total of 545 shares of Intuitive Surgical which is valued at $374,813. Intuitive Surgical makes up approx 0.18% of Ipswich Investment Management’s portfolio.Old Mutual Global Investors (uk) Ltd. reduced its stake in ISRG by selling 17,623 shares or 99.95% in the most recent quarter. The Hedge Fund company now holds 8 shares of ISRG which is valued at $5,515.Gateway Investment Advisers boosted its stake in ISRG in the latest quarter, The investment management firm added 38 additional shares and now holds a total of 38,881 shares of Intuitive Surgical which is valued at $26,160,692. Intuitive Surgical makes up approx 0.22% of Gateway Investment Advisers’s portfolio.
Intuitive Surgical closed down -3.14 points or -0.46% at $682.9 with 1,75,800 shares getting traded on Wednesday. Post opening the session at $687.64, the shares hit an intraday low of $679.1 and an intraday high of $687.64 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.
On the company’s financial health, Intuitive Surgical reported $5.62 EPS for the quarter, beating the analyst consensus estimate by $ 0.63 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $4.99. The company had revenue of $670.10 million for the quarter, compared to analysts expectations of $642.46 million. The company’s revenue was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.57 EPS.
Many Wall Street Analysts have commented on Intuitive Surgical. Northland Capital Downgraded Intuitive Surgical on Jul 21, 2016 to ” Under Perform”, Price Target of the shares are set at $600.Company shares were Reiterated by Wedbush on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 755 from a previous price target of $715 .Company shares were Reiterated by Canaccord Genuity on Jul 20, 2016 to “Buy”, Firm has raised the Price Target to $ 750 from a previous price target of $700 .
Intuitive Surgical Inc. designs manufactures and markets da Vinci Surgical Systems and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console a patient-side cart and vision system. The da Vinci Surgical System provides its operating surgeons with control range of motion tissue manipulation and three-dimensional (3-D) high-definition (HD) vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery (MIS) procedures. Its da Vinci Surgery utilizes computational robotic and imaging technologies. The Company has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System the da Vinci Si Surgical System the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company focuses on five surgical specialties: urologic surgery gynecologic surgery general surgery cardiothoracic surgery and head and neck surgery.